{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:20:54Z","timestamp":1786980054113,"version":"build-2736575974"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2021,1,6]],"date-time":"2021-01-06T00:00:00Z","timestamp":1609891200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,1,6]],"date-time":"2021-01-06T00:00:00Z","timestamp":1609891200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Childs Nerv Syst"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1007\/s00381-020-04991-y","type":"journal-article","created":{"date-parts":[[2021,1,6]],"date-time":"2021-01-06T05:08:55Z","timestamp":1609909735000},"page":"1649-1657","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Aspirin use and platelet aggregation in ischemic onset-type pediatric moyamoya patients with intractable headaches (moya-ache)"],"prefix":"10.1007","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4837-6248","authenticated-orcid":false,"given":"Yasuo","family":"Aihara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinobu","family":"Kashiwase","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kentaro","family":"Chiba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Yamaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshikazu","family":"Okada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshimi","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takakazu","family":"Kawamata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,6]]},"reference":[{"key":"4991_CR1","first-page":"1977","volume":"17","author":"H Zhang","year":"2019","unstructured":"Zhang H, Zheng L, Feng L (2019) Epidemiology, diagnosis and treatment of moyamoya disease. Exp Ther Med 17:1977\u20131984","journal-title":"Exp Ther Med"},{"key":"4991_CR2","doi-asserted-by":"crossref","unstructured":"Riordan CP, Storey A, Cote DJ, Smith ER, Scott RM (2019) Results of more than 20 years of follow-up in pediatric patients with moyamoya disease undergoing pial synangiosis. J Neurosurg Pediatr: 1\u20137","DOI":"10.3171\/2019.1.PEDS18457"},{"key":"4991_CR3","first-page":"S57","volume":"66","author":"R Espert","year":"2018","unstructured":"Espert R, Gadea M, Alino M, Oltra-Cucarella J, Perpina C (2018) Moyamoya disease: clinical, neuroradiological, neuropsychological and genetic perspective. Rev Neurol 66:S57\u2013S64","journal-title":"Rev Neurol"},{"key":"4991_CR4","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/S0090-3019(96)00358-8","volume":"47","author":"M Fukui","year":"1997","unstructured":"Fukui M (1997) Current state of study on moyamoya disease in Japan. Surg Neurol 47:138\u2013143","journal-title":"Surg Neurol"},{"key":"4991_CR5","doi-asserted-by":"publisher","first-page":"672","DOI":"10.3171\/2011.11.JNS11944","volume":"116","author":"Y Okada","year":"2012","unstructured":"Okada Y, Kawamata T, Kawashima A, Yamaguchi K, Ono Y, Hori T (2012) The efficacy of superficial temporal artery-middle cerebral artery anastomosis in patients with moyamoya disease complaining of severe headache. J Neurosurg 116:672\u2013679","journal-title":"J Neurosurg"},{"key":"4991_CR6","first-page":"39","volume":"64","author":"M Bohara","year":"2015","unstructured":"Bohara M, Sugata S, Nishimuta Y, Karki P, Nagayama T, Sakamoto S, Tokimura H, Arita K (2015) Effect of revascularization on headache associated with moyamoya disease in pediatric patients. Hiroshima J Med Sci 64:39\u201344","journal-title":"Hiroshima J Med Sci"},{"key":"4991_CR7","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1016\/j.wneu.2012.11.018","volume":"80","author":"K Chao","year":"2013","unstructured":"Chao K, Steinberg GK (2013) Headaches in children with moyamoya disease: does revascularization help? World Neurosurg 80:512\u2013513","journal-title":"World Neurosurg"},{"key":"4991_CR8","doi-asserted-by":"publisher","first-page":"477","DOI":"10.3928\/0090-4481-19950901-08","volume":"24","author":"WD Graf","year":"1995","unstructured":"Graf WD, Riback PS (1995) Pharmacologic treatment of recurrent pediatric headache. Pediatr Ann 24:477\u2013484","journal-title":"Pediatr Ann"},{"key":"4991_CR9","doi-asserted-by":"publisher","first-page":"485","DOI":"10.3171\/2017.5.PEDS17198","volume":"20","author":"H Uchino","year":"2017","unstructured":"Uchino H, Kazumata K, Ito M, Nakayama N, Houkin K (2017) Novel insights into symptomatology of moyamoya disease in pediatric patients: survey of symptoms suggestive of orthostatic intolerance. J Neurosurg Pediatr 20:485\u2013488","journal-title":"J Neurosurg Pediatr"},{"key":"4991_CR10","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1016\/j.jacc.2007.11.080","volume":"51","author":"AY Gasparyan","year":"2008","unstructured":"Gasparyan AY, Watson T, Lip GY (2008) The role of aspirin in cardiovascular prevention: implications of aspirin resistance. J Am CollCardiol 51:1829\u20131843","journal-title":"J Am CollCardiol"},{"key":"4991_CR11","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1161\/01.STR.0000209620.44017.97","volume":"37","author":"T Soman","year":"2006","unstructured":"Soman T, Rafay MF, Hune S, Allen A, MacGregor D, deVeber G (2006) The risks and safety of clopidogrel in pediatric arterial ischemic stroke. Stroke 37:1120\u20131122","journal-title":"Stroke"},{"key":"4991_CR12","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1253\/circj.CJ-11-0366","volume":"75","author":"A Curcio","year":"2011","unstructured":"Curcio A, Torella D, Indolfi C (2011) Mechanisms of smooth muscle cell proliferation and endothelial regeneration after vascular injury and stenting: approach to therapy. Circ J 75:1287\u20131296","journal-title":"Circ J"},{"key":"4991_CR13","first-page":"307","volume":"49","author":"M Iivanainen","year":"1973","unstructured":"Iivanainen M, Vuolio M, Halonen V (1973) Occlusive disease of intracranial main arteries with collateral networks (moyamoya disease) in adults. ActaNeurolScand 49:307\u2013322","journal-title":"ActaNeurolScand"},{"key":"4991_CR14","first-page":"44","volume":"12","author":"E Ikeda","year":"1993","unstructured":"Ikeda E, Hosoda Y (1993) Distribution of thrombotic lesions in the cerebral arteries in spontaneous occlusion of the circle of Willis: cerebrovascular moyamoya disease. ClinNeuropathol 12:44\u201348","journal-title":"ClinNeuropathol"},{"key":"4991_CR15","unstructured":"Hosoda Y (1984) Pathology of so-called \u201cspontaneous occlusion of the circle of Willis.\u201d PatholAnnu 19(Pt 2):221\u2013244"},{"key":"4991_CR16","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1016\/j.amjsurg.2004.08.061","volume":"188","author":"JA Davis","year":"2004","unstructured":"Davis JA, Brown AT, Alshafie T, Poirier LA, Cruz CP, Wang Y, Eidt JF, Moursi MM (2004) Saratin (an inhibitor of platelet-collagen interaction) decreases platelet aggregation and homocysteine-mediated postcarotidendarterectomy intimal hyperplasia in a dose-dependent manner. Am J Surg 188:778\u2013785","journal-title":"Am J Surg"},{"key":"4991_CR17","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1067\/mva.2001.116801","volume":"34","author":"CP Cruz","year":"2001","unstructured":"Cruz CP, Eidt J, Drouilhet J, Brown AT, Wang Y, Barnes CS, Moursi MM (2001) Saratin, an inhibitor of von Willebrand factor-dependent platelet adhesion, decreases platelet aggregation and intimal hyperplasia in a rat carotid endarterectomy model. J Vasc Surg 34:724\u2013729","journal-title":"J Vasc Surg"},{"key":"4991_CR18","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1038\/jcbfm.2008.67","volume":"28","author":"KH Jung","year":"2008","unstructured":"Jung KH, Chu K, Lee ST, Park HK, Kim DH, Kim JH, Bahn JJ, Song EC, Kim M, Lee SK, Roh JK (2008) Circulating endothelial progenitor cells as a pathogenetic marker of moyamoya disease. J Cereb Blood Flow Metab 28:1795\u20131803","journal-title":"J Cereb Blood Flow Metab"},{"key":"4991_CR19","first-page":"21","volume":"6","author":"N Tyutyulkova","year":"1984","unstructured":"Tyutyulkova N, Gorantcheva Y, Lisitchkov T (1984) Effect of diclofenac sodium (feloran) on platelet aggregation. Methods Find Exp Clin Pharmacol 6:21\u201325","journal-title":"Methods Find Exp Clin Pharmacol"},{"key":"4991_CR20","first-page":"577","volume":"119","author":"E Auriel","year":"2014","unstructured":"Auriel E, Regev K, Korczyn AD (2014) Nonsteroidal anti-inflammatory drugs exposure and the central nervous system. HandbClinNeurol 119:577\u2013584","journal-title":"HandbClinNeurol"},{"key":"4991_CR21","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1172\/JCI110814","volume":"71","author":"GA FitzGerald","year":"1983","unstructured":"FitzGerald GA, Oates JA, Hawiger J, Maas RL, Roberts LJ 2nd, Lawson JA, Brash AR (1983) Endogenous biosynthesis of prostacyclin and thromboxane and platelet function during chronic administration of aspirin in man. J Clin Invest 71:676\u2013688","journal-title":"J Clin Invest"},{"key":"4991_CR22","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/s11916-005-0017-4","volume":"9","author":"GW Williams","year":"2005","unstructured":"Williams GW (2005) An update on nonsteroidal anti-inflammatory drugs and cyclooxygenase-2 inhibitors. Curr Pain Headache Rep 9:377\u2013389","journal-title":"Curr Pain Headache Rep"},{"key":"4991_CR23","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/S0014-2999(98)00078-8","volume":"347","author":"S Kawai","year":"1998","unstructured":"Kawai S, Nishida S, Kato M, Furumaya Y, Okamoto R, Koshino T, Mizushima Y (1998) Comparison of cyclooxygenase-1 and -2 inhibitory activities of various nonsteroidal anti-inflammatory drugs using human platelets and synovial cells. Eur J Pharmacol 347:87\u201394","journal-title":"Eur J Pharmacol"},{"issue":"Suppl 5","key":"4991_CR24","doi-asserted-by":"publisher","first-page":"S211","DOI":"10.1086\/317517","volume":"31","author":"DL Simmons","year":"2000","unstructured":"Simmons DL, Wagner D, Westover K (2000) Nonsteroidal anti-inflammatory drugs, acetaminophen, cyclooxygenase 2, and fever. Clin Infect Dis 31(Suppl 5):S211-218","journal-title":"Clin Infect Dis"},{"issue":"Suppl 5","key":"4991_CR25","doi-asserted-by":"publisher","first-page":"S202","DOI":"10.1086\/317520","volume":"31","author":"RM Botting","year":"2000","unstructured":"Botting RM (2000) Mechanism of action of acetaminophen: is there a cyclooxygenase 3? Clin Infect Dis 31(Suppl 5):S202-210","journal-title":"Clin Infect Dis"},{"key":"4991_CR26","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1161\/STROKEAHA.118.022800","volume":"50","author":"KP Guilliams","year":"2019","unstructured":"Guilliams KP, Kirkham FJ, Holzhauer S, Pavlakis S, Philbrook B, Amlie-Lefond C, Noetzel MJ, Dlamini N, Sharma M, Carpenter JL, Fox CK, Torres M, Ichord RN, Jordan LC, Dowling MM (2019) Arteriopathy influences pediatric ischemic stroke presentation, but sickle cell disease influences stroke management. Stroke 50:1089\u20131094","journal-title":"Stroke"},{"key":"4991_CR27","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1161\/01.ATV.13.8.1171","volume":"13","author":"JM Herbert","year":"1993","unstructured":"Herbert JM, Tissinier A, Defreyn G, Maffrand JP (1993) Inhibitory effect of clopidogrel on platelet adhesion and intimal proliferation after arterial injury in rabbits. Arterioscler Thromb 13:1171\u20131179","journal-title":"Arterioscler Thromb"},{"key":"4991_CR28","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1097\/00000658-198002000-00018","volume":"191","author":"RL McCann","year":"1980","unstructured":"McCann RL, Hagen PO, Fuchs JC (1980) Aspirin and dipyridamole decrease intimal hyperplasia in experimental vein grafts. Ann Surg 191:238\u2013243","journal-title":"Ann Surg"},{"key":"4991_CR29","first-page":"18","volume":"108","author":"P Pergami","year":"2012","unstructured":"Pergami P, Seemaladinne N (2012) Stroke in children: need for increased awareness. W V Med J 108:18\u201319","journal-title":"W V Med J"},{"key":"4991_CR30","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1016\/j.wneu.2017.06.057","volume":"105","author":"Y Zhao","year":"2017","unstructured":"Zhao Y, Zhang Q, Zhang D, Zhao Y (2017) Effect of aspirin in postoperative management of adult ischemic moyamoya disease. World Neurosurg 105:728\u2013731","journal-title":"World Neurosurg"},{"key":"4991_CR31","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1111\/j.1468-1331.2011.03481.x","volume":"19","author":"M Kraemer","year":"2012","unstructured":"Kraemer M, Berlit P, Diesner F, Khan N (2012) What is the expert\u2019s option on antiplatelet therapy in moyamoya disease? Results of a worldwide Survey. Eur J Neurol 19:163\u2013167","journal-title":"Eur J Neurol"},{"key":"4991_CR32","doi-asserted-by":"publisher","first-page":"3373","DOI":"10.1016\/j.jstrokecerebrovasdis.2018.07.041","volume":"27","author":"T Chiba","year":"2018","unstructured":"Chiba T, Setta K, Shimada Y, Yoshida J, Fujimoto K, Tsutsui S, Yoshida K, Kobayashi M, Kubo Y, Fujiwara S, Terasaki K, Ogasawara K (2018) Comparison of effects between clopidogrel and cilostazol on cerebral perfusion in nonsurgical adult patients with symptomatically ischemic moyamoya disease: subanalysis of a prospective cohort. J Stroke Cerebrovasc Dis 27:3373\u20133379","journal-title":"J Stroke Cerebrovasc Dis"}],"container-title":["Child's Nervous System"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00381-020-04991-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00381-020-04991-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00381-020-04991-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,29]],"date-time":"2021-04-29T05:11:20Z","timestamp":1619673080000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00381-020-04991-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,6]]},"references-count":32,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["4991"],"URL":"https:\/\/doi.org\/10.1007\/s00381-020-04991-y","relation":{},"ISSN":["0256-7040","1433-0350"],"issn-type":[{"value":"0256-7040","type":"print"},{"value":"1433-0350","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,6]]},"assertion":[{"value":"31 March 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 November 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors have no personal financial or institutional interest in any of the materials or devices described in this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This research was conducted with the acknowledgement of the Ethics Committee of the Tokyo Women\u2019s Medical College. All the staff associated with this research acted in compliance with \u201cthe Declaration of Helsinki\u201d (revised in October 2013) and \u201cEthics Guidelines for Clinical Studies\u201d revised on July 31, 2008.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical considerations"}}]}}